NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.38 -1.56%

Quarterly report 2023-Q3
added 11-09-2023

report update icon

NeuBase Therapeutics P/CF Ratio 2011-2024 | NBSE

Annual P/CF Ratio NeuBase Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- -1.45 -13.5 -12.6 -1.24 -1.42 -6.07 -7.65 -17.9 -50 -38 -25

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.24 -50 -15.9